A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 165
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : EC
Long Form : esophageal carcinoma
No. Year Title Co-occurring Abbreviation
2019 ADC correlation with Sirtuin1 to assess early chemoradiotherapy response of locally advanced esophageal carcinoma patients. ADC, CRT, DWI, ESCC, IHC, MRI, ROC, ROIs, SIRT1
2019 Analysis of the function of MAGE-A in esophageal carcinoma by bioinformatics. ESCC, GO, KEGG, MAGE-A, qPCR
2019 Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma. AUC, ELISA, ESCC, miRNAs, ROC, RT-qPCR
2019 Circular RNA hsa_circ_0030018 acts as a sponge of miR-599 to aggravate esophageal carcinoma progression by regulating ENAH expression. circRNAs, EMT, ENAH
2019 Dosimetric comparison of TomoDirect, helical tomotherapy, VMAT, and ff-IMRT for upper thoracic esophageal carcinoma. CIs, DVH, ESCC, ff-IMRT, HI, HT, MLD, TD, VMAT
2019 Down-regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA-145-mediated inhibition of FSCN1. lncRNA, miR-145, PVT1
2019 Endoscopic therapy and surveillance versus esophagectomy for early esophageal adenocarcinoma: A review of early outcomes and cost analysis. ---
2019 Immunohistochemical analysis of the expression of cancer-associated fibroblast markers in esophageal cancer with and without neoadjuvant therapy. CAFs, ngTMA
2019 Investigation into the expression levels of MAGEA6 in esophageal squamous cell carcinoma and esophageal adenocarcinoma tissues. EAC, ESCC, MAGE, MAGEA6, RT-qPCR
10  2019 Lentiviral-Mediated Overexpression of MicroRNA-141 Promotes Cell Proliferation and Inhibits Apoptosis in Human Esophageal Squamous Cell Carcinoma. ESCC, miRNA, miRNAs, UTR
11  2019 Lymphovascular invasion as a poor prognostic indicator in thoracic esophageal carcinoma: a systematic review and meta-analysis. CI, HR, LVI, OS, RFS
12  2019 miRNA‑30a‑3p inhibits metastasis and enhances radiosensitivity in esophageal carcinoma by targeting insulin‑like growth factor 1 receptor. EMT, miRNAs
13  2019 Pathological response and serum VEGF changes during chemoradiotherapy for esophageal carcinoma. CR, CRT, OS, PFS, VEGF
14  2019 Potential Role of circPVT1 as a proliferative factor and treatment target in esophageal carcinoma. ---
15  2019 Rac GTPase-Activating Protein 1 (RACGAP1) as an Oncogenic Enhancer in Esophageal Carcinoma. RACGAP1, TNM
16  2019 Reduced miR-203 predicts metastasis and poor survival in esophageal carcinoma. GEO
17  2019 Serum pepsinogen assay is not recommended for the diagnosis of esophageal squamous cell carcinoma: a systematic review and meta-analysis. ESCC, PG I, PGR, SROC
18  2019 Silencing lncRNAs PVT1Upregulates miR-145 and Confers Inhibitory Effects on Viability, Invasion, and Migration in EC. FSCN1, lncRNA, miR-145, PVT1, RIP
19  2019 The research advances of exosomes in esophageal cancer. ---
20  2019 Volumetric changes in pharyngeal structures following head and neck cancer chemoradiation therapy. BOT, CI, CRT, HNSCC, PCs, RPS
21  2018 Clinical significance of tumor necrosis factor receptor 2 in middle and lower thoracic esophageal squamous cell carcinoma. ESCC, IHC, OS, TNFR2
22  2018 Comparative study of computed tomography (CT) and pathological diagnosis toward mediastinal lymph node metastasis in esophageal carcinoma. AUC, CT, MLNM, ROC
23  2018 Cullin7 promotes epithelial‑mesenchymal transition of esophageal carcinoma via the ERK‑SNAI2 signaling pathway. CUL7, EMT, IHC
24  2018 Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patterns. EAC, ESCC
25  2018 Expression and clinical significance of retinoid X receptor alpha in esophageal carcinoma. DFS, IHC, OS, RT-PCR, RXRalpha
26  2018 Feasibility of a single mediastinal drain through the abdominal wall after esophagectomy. ANOVA, MIE, VAS
27  2018 Impact of high body mass index on surgical outcomes and long-term survival among patients undergoing esophagectomy: A meta-analysis. CI, HR, OR, OS
28  2018 Meta-analysis of survival benefit with postoperative chemoradiotherapy in patients of lymph node positive esophageal carcinoma. CRT, RR, SA, SCC
29  2018 Predictors of Survival After Treatment of Oligometastases After Esophagectomy. CT-RT, PRS, TTR
30  2018 Preoperative plasma fibrinogen is associated with poor prognosis in esophageal carcinoma: a meta-analysis. CIs, HRs, PPF
31  2018 Prevalence of the integration status for human papillomavirus 16 in esophageal carcinoma samples. HPV, PCR
32  2018 Prognostic significance of miR-21 and PDCD4 in patients with stage II esophageal carcinoma after surgical resection. OS, PDCD4, PFS
33  2018 Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis. CIs, EAC, ESCC, HRs, miRNAs, OS
34  2018 Programmed death ligand 1 expression in esophageal cancer following definitive chemoradiotherapy: Prognostic significance and association with inflammatory biomarkers. CRT, LMR, NLR, OS, PD-L1, PLR
35  2018 Retinoic Acid Receptor alpha Knockdown Suppresses the Tumorigenicity of Esophageal Carcinoma via Wnt/beta-catenin Pathway. RARalpha
36  2018 Thymoquinone Augments Cisplatin-Induced Apoptosis on Esophageal Carcinoma Through Mitigating the Activation of JAK2/STAT3 Pathway. TQ
37  2017 Clinical implications of vasohibin-1 in esophageal carcinoma cells: Inhibition of cell growth and migration. VASH1
38  2017 Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma: a single institutional experience. IMPT
39  2017 Decreased expression of CD63 tetraspanin protein predicts elevated malignant potential in human esophageal cancer. MMP
40  2017 Dietary fat intake and risk of esophageal carcinoma: a meta-analysis of observational studies. CI, EAC, ESCC, MUFA, PUFA, RR, SFA
41  2017 DKK1 maintained cancer stem-like properties of esophageal carcinoma cells via ALDH1A1/SOX2 axis. ALDH1A1, DKK1
42  2017 Downregulation of MACC1 inhibits the viability, invasion and migration and induces apoptosis in esophageal carcinoma cells through the phosphatase and tensin homolog/phosphoinositide 3-kinase/protein kinase B signaling pathway. PI3K, PTEN, si
43  2017 Efficacy and safety of chemoradiation therapy compared with chemotherapy for esophageal carcinoma: An updated meta-analysis of randomized controlled trials. CRT, CT, HR, OS, pCR, PFS, RCTs, RR
44  2017 Endoscopic ultrasonography for preoperative staging of esophageal carcinoma. EUS
45  2017 Expression and function of tetraspanin 1 in esophageal carcinoma. siRNA, TSPAN1
46  2017 Genetic variability in LMP2 and LMP7 is associated with the risk of esophageal squamous cell carcinoma in the Kazakh population but is not associated with HPV infection. ESCC, HPV, PCR-RFLP, SNPs
47  2017 Integration of human papillomavirus 16 in esophageal carcinoma samples. HPV, PCR
48  2017 Meta-analysis of microRNAs as potential biomarkers for detecting esophageal carcinoma in Asian populations. miRNAs
49  2017 miR-195 Regulates Proliferation and Apoptosis through Inhibiting the mTOR/p70s6k Signaling Pathway by Targeting HMGA2 in Esophageal Carcinoma Cells. ---
50  2017 Overexpression of CHD1L is associated with poor survival and aggressive tumor biology in esophageal carcinoma. CHD1L
51  2017 Pathologic lymph node ratio is a predictor of esophageal carcinoma patient survival: a literature-based pooled analysis. CIs, HR, LNR, OS
52  2017 Radiomic analysis in contrast-enhanced CT: predict treatment response to chemoradiotherapy in esophageal carcinoma. ANN, CRT, CT, ROC, SVM
53  2017 The prognostic value of tumor length to resectable esophageal squamous cell carcinoma: a retrospective study. ESCC, ROC
54  2017 Tyrosine kinase inhibitor induced growth factor receptor upregulation enhances the efficacy of near-infrared targeted photodynamic therapy in esophageal adenocarcinoma cell lines. EAC, NIR-tPDT, TKI
55  2017 [Impact factor of postoperative prognosis of esophageal cancer patients with stage pT2N0~1M0]. OS, PFS
56  2016 A Meta-Analysis and Systematic Review on the Association between Human Papillomavirus (Types 16 and 18) Infection and Esophageal Cancer Worldwide. HPV, RR
57  2016 Association of gastrointestinal gland cancer susceptibility loci with esophageal carcinoma among the Chinese Han population: a case-control study. HWE, SNPs
58  2016 BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10. BAG3
59  2016 Cellular Retinoic Acid Binding Protein 2 Is Strikingly Downregulated in Human Esophageal Squamous Cell Carcinoma and Functions as a Tumor Suppressor. CRABP2, ESCC, RA, RAR
60  2016 Enhanced Expression of Fibroblast Growth Factor Receptor 3 IIIc Promotes Human Esophageal Carcinoma Cell Proliferation. ESCC, FGFRs, NCM
61  2016 Episomal Lentiviral Vector-Mediated miR-145 Overexpression Inhibits Proliferation and Induces Apoptosis of Human Esophageal Carcinomas Cells. EGFP, miR-145
62  2016 Esophageal cancer stem cells and implications for future therapeutics. CSCs
63  2016 Genetic risk of subsequent esophageal cancer in lymphoma and breast cancer long-term survival patients: a pilot study. EADC, ESCC
64  2016 Identification of the Key Genes and Pathways in Esophageal Carcinoma. DEGs, GO, KEGG, PPI, qRT-PCR
65  2016 Impact of IGF-1, IGF-1R, and IGFBP-3 promoter methylation on the risk and prognosis of esophageal carcinoma. IHC, LNM, MSP
66  2016 Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice. ENI, IFRT, RT
67  2016 Lymphatic spreading and lymphadenectomy for esophageal carcinoma. ---
68  2016 Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis. CIs, nCRT, NCRTS, RR, SA, SRs
69  2016 Overexpressed HDAC4 is associated with poor survival and promotes tumor progression in esophageal carcinoma. CDK, EMT, ESCC, HDACs
70  2016 Prognostic significance of circulating tumor cells in esophageal carcinoma: a meta-analysis. CIs, CTCs, HR, OR, PCR, SCC, TNM
71  2016 Role of human epidermal growth factor receptor 2 as a prognostic factor for survival in esophageal carcinoma: evidence from 2872 subjects. CIs, DFS, HER2, HR, OS
72  2015 A Population-Based Examination of the Surgical Outcomes for Patients with Esophageal Sarcoma. ES, GIST, OS, SEER
73  2015 Computed tomography-based distribution of involved lymph nodes in patients with upper esophageal cancer. CT, CTVn
74  2015 Efficacy of dendritic cell-cytokine-induced killer immunotherapy plus intensity-modulated radiation therapy in treating elderly patients with esophageal carcinoma. CIK, DC, IMRT
75  2015 Epidermal Growth Factor (EGFR) copy number aberrations in esophageal and gastro-esophageal junctional carcinoma. EGFR, FFPE, FISH
76  2015 Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma. CRT, OS
77  2015 Intended use for a neoadjuvant chemoradiation response prediction test for locally advanced esophageal adenocarcinoma: a survey analysis of thoracic surgeons in the US. exCTRT, IHC, neoCTRT, pathCR
78  2015 miR-106a* inhibits the proliferation of esophageal carcinoma cells by targeting CDK2-associated Cullin 1 (CACUL1). CACUL1
79  2015 miRNA-1207-5p is associated with cancer progression by targeting stomatin-like protein 2 in esophageal carcinoma. STOML2
80  2015 Novel perspectives of long non-coding RNAs in esophageal carcinoma. lncRNAs
81  2015 Surgical outcomes of pulmonary metastases from esophageal carcinoma diagnosed by both pathological and clinical criteria. OS, SCC
82  2015 Teeth loss, teeth brushing and esophageal carcinoma: a systematic review and meta-analysis. CIs, ORs
83  2015 The effect of recombinant lentiviral vector encoding miR-145 on human esophageal cancer cells. ---
84  2015 The Glasgow Prognostic Score. An useful tool to predict survival in patients with advanced esophageal squamous cell carcinoma. GPS
85  2015 The K167I variant of DNA polymerase beta that is found in Esophageal Carcinoma patients impairs polymerase activity and BER. BER, pol beta
86  2014 ABO blood group and esophageal carcinoma risk: from a case-control study in Chinese population to meta-analysis. CI, ORs
87  2014 Accuracy of endoscopic ultrasound in the diagnosis of T2N0 esophageal cancer. EUS
88  2014 Characteristics of brain metastases from esophageal carcinoma. BM, SmCC, SqCC
89  2014 Diagnostic application of PIK3CA mutation analysis in Chinese esophageal cancer patients. ARMS, ME-Liquidchip
90  2014 Enhancement of silencing DNA polymerase beta on the radiotherapeutic sensitivity of human esophageal carcinoma cell lines. BER, CCK-8, siRNA
91  2014 Human umbilical cord mesenchymal stem cells promote carcinoma growth and lymph node metastasis when co-injected with esophageal carcinoma cells in nude mice. BM-MSCs, hUCMSCs
92  2014 Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer. BMT, DM, LR
93  2014 Prognostic significance of beta-catenin expression in patients with esophageal carcinoma: a meta-analysis. OS
94  2014 RNAi screening identifies HAT1 as a potential drug target in esophageal squamous cell carcinoma. HAT1, HATs
95  2014 Short- and long-term outcomes of definitive chemoradiotherapy in patients with esophageal carcinoma aged ≥75 years. CRT, RT
96  2014 Suppressing the formation of lipid raft-associated Rac1/PI3K/Akt signaling complexes by curcumin inhibits SDF-1alpha-induced invasion of human esophageal carcinoma cells. CXCR4, MMP-2, PI3K, Rac1, SDF-1alpha
97  2014 Synuclein-gamma predicts poor clinical outcome in esophageal cancer patients. CI, SNCG
98  2013 A relationship between replication protein A and occurrence and prognosis of esophageal carcinoma. RPA
99  2013 Agrocybe aegerita polysaccharide combined with chemotherapy improves tumor necrosis factor-alpha and interferon-gamma levels in rat esophageal carcinoma. IFN-gamma, TNF-alpha
100  2013 Barrett associated MHC and FOXF1 variants also increase esophageal carcinoma risk. EAC, MHC, RT-PCR